
    
      This is a non- interventional, retrospective epidemiological study of participants with MM.
      The study will characterize MM participants with symptomatic R/R disease.

      The study will enroll approximately 151 participants. The study will have a retrospective
      data collection referring to previous 3 years from participants' records and medical charts
      regarding diagnosis, disease activity, treatment patterns, and healthcare resources while
      quality of life (QoL) will be obtained from European Organization for Research and Treatment
      of Cancer Quality of Life Questionnaire (EORTC QLQ)-C30 and EORTC QLQ-MY20 questionnaires.
      All participants will be enrolled in one observational group.

      This multi-center trial will be conducted in Portugal. The overall time to participate in
      this study is approximately 24 months.
    
  